Tags: diabetes

8/16/2018

Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier

6/22/2018

One blood test to diagnose diabetes? HealthDay doesn’t address harms of overdiagnosis and overtreatment

5/31/2018

LA Times provides careful take on early brain/diabetes research–except for the headline

3/5/2018

NPR story about online weight loss program left out a key detail: How much does it cost?

12/7/2017

When weight loss is the intervention, it’s still important to talk about costs and harms

10/3/2017

AP’s write-up on a new continuous blood sugar monitor–where’s the proof that it works?

3/13/2017

Can these 10 foods really ‘cut risk of early death’? NPR overstates the evidence

6/16/2016

Independent source and costs: All that’s missing from otherwise solid Reuters story on Victoza

5/23/2016

Guardian predicts end to insulin shots based on rehashed news release, mouse research

5/20/2016

Reuters story on oral insulin trial needed sources beyond drug company CEO

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

National Breast Cancer Coalition @NBCCStopBC·

A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold

Reply on Twitter 1520768892888567810 Retweet on Twitter 15207688928885678101 Like on Twitter 15207688928885678103 Twitter 1520768892888567810

HealthNewsReview.org @HealthNewsRevu·

Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's ⁦@CarlaKJohnson⁩. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d

Reply on Twitter 1516522980385472513 Retweet on Twitter 1516522980385472513 Like on Twitter 15165229803854725134 Twitter 1516522980385472513